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Psoriatic arthritis (PsA) has been deﬁned as an inﬂammatory arthritis associated with psoriasis that may affect as
many as 30% of psoriasis patients. Epidemiological study reported strong familial clustering of PsA although the
precise etiology of PsA is poorly understood. Recently, a genomewide linkage scan in PsA revealed a LOD score of
2.17 on chromosome 16q and provided strong evidence for a paternal imprinting effect. That region surrounds a
psoriasis susceptibility locus including the CARD15 gene which has convincingly been shown to confer
susceptibility to Crohn’s disease. The existence of a common susceptibility gene for psoriasis/PsA and Crohn
disease was recently demonstrated by evidence of association of CARD15 polymorphisms with PsA. To conﬁrm
these results in an independent population, we analyzed a data set of 193 Italian PsA patients and 150 controls for
CARD15 polymorphisms (R702W, G908R and leu1007ﬁnsC) previously demonstrated associated with PsA. Here we
report no evidence for association in the examined population for CARD15 polymorphisms, suggesting that the
positive association previously reported in a genetically isolated population was the result of a linkage
disequilibrium due to a founder effect.
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Psoriasis (MIM 177900) is a chronic inflammatory skin
disorder affecting approximately 2% of the Caucasian
population (Nevitt and Hutchinson, 1996). Psoriatic arthritis
(PsA) has been defined as an inflammatory arthritis
associated with psoriasis that may affect as many as 30%
of psoriasis patients (Wright and Moll, 1976). The precise
etiology of PsA is unknown but a large epidemiological
study in the United Kingdom reported strong familial
clustering of PsA (Moll and Wright, 1973). Association
studies have suggested an involvement of the major
histocompatibility complex (MHC) in PsA susceptibility
(Gladman et al, 2002). Recently, a genome-wide linkage
scan in PsA, using 1000 microsatellite markers in 178
patients with PsA from 39 families, revealed a LOD score of
2.17 on chromosome 16q (Karason et al, 2003). Further
analysis provided evidence for a paternal imprinting effect
resulting in a LOD score of 4.19. The peak of association fell
within a genomic region containing the CARD15 gene on
human chromosome 16 (MIM 605956). The CARD15 gene
has convincingly been shown to confer susceptibility to
Crohn’s disease in Caucasians (MIM 266600) (Hugot et al,
2001). Interestingly, this region contains a psoriasis sus-
ceptibility locus (Nair et al, 1997). Epidemiological studies
further support the possibility of the existence of a common
susceptibility locus for psoriasis/PsA and Crohn diseases
(Nair et al, 1997). A recent study demonstrated that
CARD15 polymorphisms are significantly associated to
PsA, providing evidence for a possible involvement of
CARD15 in the pathogenesis of PsA (Rahman et al, 2003a, b).
In order to confirm these results in an independent
population, we analyzed a dataset of 193 Italian PsA
patients and 150 controls (details in Borgiani et al, 2002).
At the time of diagnosis, the mean age was 46.2-y old for
patients and 48.6-y old for controls; the sex ratio (M/F)
was 2:1 for both patients and controls. This sample was
screened for allelic and genotypic frequencies using the
same CARD15 polymorphisms (R702W, G908R and
leu1007finsC) investigated by Rahman et al (2003a, b).
Patients were recruited from all Italian regions at the
Departments of Rheumatology and Dermatology, respec-
tively, of ‘‘La Sapienza’’ and ‘‘Tor Vergata’’ Universities of
Rome (Italy). The PsA was diagnosed according to the
ESSG criteria (Dougados et al, 1991). All patients granted
their informed consent for participating in this study.
PsA was oligoarticular in 45% of patients, polyarticular in
55% of patients, and axial in 41% of patients. The control
subjects, matched for age and gender, were not related and
were all examined to exclude the presence of Crohn
disease, Ps, and PsA.
We compared genotypic and allelic frequencies between
patients and controls, and among the categorical classes of
subgroups using a t-test. The genotypic frequencies of the
wild-type homozygotes and heterozygotes of the three
studied polymorphisms in patients and controls are detailed
in Table I. No evidence for association was detected in the
examined population for the analyzed polymorphisms;
however, a statistically insignificant increase in the G908R
heterozygotes proportion was observed in the patientAbbreviation: LOD, log rather of odds; PsA, psoriatic arthritis
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group. We further compared the PsA and control groups
with the psoriasis patients without PsA, as previously
described (Borgiani et al, 2002; Nair et al, 2001), but we
failed to detect evidence for a linear correlation (Mantel—
Haenszel’s test of linearity: NS). This may support the theory
that PsA and Ps are disparate in their etiology (Reis et al,
2003). To evaluate the existence of an association with
particular subgroups within the cohort examined, we
compared the genotypic distribution of the G908R poly-
morphisms with the following variables: gender, age at
onset of Ps and PsA, type of arthritis (oligoarticular,
polyarticular and axial), number of involved joints, score of
sacroiliac joints involvement, number of syndesmophytes,
ESR and PCR values, and HLA-C genotypes. No significant
correlations were detected.
In conclusion, our data do not support the existence of a
genetic association between PsA and CARD15 polymorph-
isms. It must be emphasized that the first report was
obtained in a genetically isolated population (Newfound-
land). It is therefore plausible that the positive association
found in this population is the result of a linkage
disequilibrium due to a founder effect (Rahman et al,
2003b). Thus, CARD15 itself could be a genetic marker, in
linkage disequilibrium with the true susceptibility gene. The
positive association detected in the first report could be
therefore due to an enhanced signal-to-noise ratio typically
observed in homogeneous populations.
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Table I. Frequency of the CARD15 genotypes detected in patients and in controls
R702W G908R Leu1007ﬁnsC
(C/C) (C/T) (G/G) (G/C) (/) (/þ )
Patients (n¼193) 0.990 0.010 0.928 0.072 0.979 0.021
Controls (n¼ 150) 0.987 0.013 0.967 0.033 0.975 0.025
Pearson’s w2-test was not significant.
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